The abstract is read at the publisher; the summary is JClub's.
Estimated all-cause mortality for invasive aspergillosis is 26·7% at 4 weeks and rises to 57·2% at 2 years in pooled individual patient data.
- Why it matters: Real-world, contemporary mortality estimates and prognostic subgroup patterns for invasive aspergillosis are limited, despite ongoing diagnostic and treatment advances.
- What they did: A systematic review and one-stage IPD meta-analysis pooled 3880 patients from 46 studies, estimating mortality at 4, 6, 12, 24 weeks, 1 year, and 2 years after diagnosis.
- The result: Mortality was 57·1% for ICU and 46·7% in-hospital; 4-week mortality was highest with ICU admission (42·9%) and in brain invasive aspergillosis (40·4%).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.